Boye Mark is a Principal Research Scientist at Eli Lilly and Company, where they have been since 2012, focusing on advanced analytics and health outcomes modeling. They previously served as a Researcher at Eli Lilly and Company from 2006 to 2012 and held managerial roles at Pfizer from 2001 to 2003. Boye earned several degrees, including a PhD in Pharmaceutical Administration from The Ohio State University and an MBA in Marketing from Youngstown State University. They have a strong foundation in health policy, epidemiology, and biostatistics, demonstrated by their various academic achievements.
This person is not in the org chart
This person is not in any teams
This person is not in any offices